AKOYA BIOSCIENCES INC (AKYA)
US00974H1041 - Common Stock
ChartMill assigns a Buy % Consensus number of 77% to AKYA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.77. This target is 78.02% above the current price.
AKYA was analyzed by 15 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about AKYA.
In the previous month the buy percentage consensus was at a similar level.
AKYA was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-19 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-11-15 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-15 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2024-08-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-06 | BTIG | Downgrade | Buy -> Neutral |
| 2024-08-06 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-08-06 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-08-06 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-06-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-05-14 | BTIG | Maintains | Buy -> Buy |
| 2024-05-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-05 | UBS | Maintains | Buy -> Buy |
| 2024-03-05 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-12-14 | Guggenheim | Initiate | Neutral |
| 2023-11-13 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2023-11-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-12 | UBS | Maintains | Buy -> Buy |
| 2023-08-08 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-08-08 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-05-10 | Morgan Stanley | Maintains | Overweight |
| 2023-03-21 | Stephens & Co. | Reiterate | Overweight |
| 2023-03-08 | Morgan Stanley | Maintains | Overweight |
| 2022-11-03 | Capital One | Initiate | Overweight |
| 2022-10-06 | Stephens & Co. | Initiate | Overweight |
| 2022-08-17 | Piper Sandler | Maintains | Overweight |
| 2022-06-22 | BTIG | Initiate | Buy |
| 2022-05-16 | Piper Sandler | Maintains | Overweight |